Most patients with persistent pulmonary symptoms after recovering from mild to moderate COVID-19 infection have normal ...

Columnist Caroline Gainer explains the risk of developing shingles for people with COPD, who often have weakened immune ...

Roughly 6 months after starting tezepelumab for severe asthma, many patients reduced OCS dependence and meaningfully improved ...

Adding sotatercept to standard therapy within a year of diagnosis lowers the risk for clinical worsening in patients with ...

Glucagon-like peptide-1 (GLP-1) drugs mimic the GLP-1 hormone, which helps control insulin and blood sugar levels, decreases ...

Researchers assessed disparities in COPD clinical trial participation based on gender, COPD severity, and geography and evaluated gender representation among researchers.

Inhaled corticosteroids pose long-term risks in COPD management, prompting careful screening and potential de-escalation ...

Adults with COPD receiving roflumilast had a smaller COPD exacerbation rate at 1 year vs. those receiving azithromycin but ...

Pulmonary arterial hypertension (PAH) is a rare condition that's difficult to treat. The hallmarks of the disease—narrowing ...

The Polaris Global Equity Composite gained 5.04% (net of fees) for the quarter, while the MSCI World Index returned 7.36%.

Climate change exacerbates health emergencies, affecting outcomes and healthcare access due to natural disasters like ...